The Egyptian Journal of Chest Diseases and Tuberculosis 2020, 69:242-247 for mortality, the underlying etiology for this obesity paradox may be not evident however correlation with the fat distribution type is recommended.
Introduction
Pulmonary hypertension (PH) is a chronic devastating disease. Obese patients with PH seems to have better outcomes as regards survival, a phenomenon which has been known recently as 'obesity paradox.' Aim of the study To highlight the impact of obesity on the severity of PH via correlating BMI with the different variables of risk stratification for first-year mortality. Patients and methods Eighty five adult pulmonary arterial hypertension patients were enrolled in our study, classified according to their BMI into normal, overweight, and obese groups. They were subjected to clinical assessment, anthropometric measurements, echocardiography, and right heart catheterization.
Results
The mean age of patients was 38.8 years (±13.57 years), female sex was the predominant. No significant statistical differences were noticed as regards the clinical presentation, hemodynamics as cardiac index, central venous oxygen saturation. Mean of right atrial pressure was lower among overweight patients significantly, 6 min walk distance was higher in overweight group than the other groups. Obese group showed the least percentage of high risk pulmonary arterial hypertension patients among the three groups.
Conclusion
In spite that obese patients have the lowest exercise tolerance and the highest mean right atrial pressure, yet they have the lowest percentage of high risk patients
Introduction
Pulmonary hypertension (PH) is a debilitating disease showed a progressive increase in the pulmonary artery pressure (PAP) and the pulmonary vascular resistance, diagnosed when the mean pulmonary artery pressure (mPAP) reaches or exceeds 25 mmHg at rest as measured by right heart catheterization (RHC) [1] . Pathophysiologically, PH could be classified into precapillary and postcapillary, differentiated by the value of the pulmonary capillary wedge pressure. PH, if not treated, is known to be associated with a high mortality rate. The average years of survival for PH patients not receiving treatment were 2.8 years, with approximated survival rates of 68, 48, and 34% at 1, 3, and 5 years, respectively [2] . The most commonly used survival predictors are 6 min walk distance (6MWD), functional class, mean right atrial pressure (mRAP), mPAP, pulmonary vascular resistance and cardiac index (CI) [3, 4] . Evaluation and risk stratification of patients with PH could be done utilizing several tests from which cardiopulmonary exercise testing and 6MWD being the most widely used in practice [5] . 6MWD is a simple, inexpensive, reproducible, and easily performed test by most patients, assessing different physiological parameters. However, 6MWD can be influenced by other factors as age, sex, height, and weight (i.e. BMI) [6] . BMI is a widely accepted measurement of weight in relation to height. In spite that high BMI is associated with increased risk of cardiovascular diseases and death, it was inversely related to many other chronic diseases as chronic obstructive pulmonary disease, coronary artery diseases [7] . Insufficient data is available as regards the impact of BMI on the prognosis and the mortality risk of PH patients, in one study conducted on 105 PH patients, obesity paradox was described, where lower mortality rates were observed in higher BMI patients [8] .
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Aim of the study
To highlight the impact of obesity on the severity of PH via correlating BMI with the different items of risk stratification for first-year mortality.
Patients and methods
A prospective cohort study was conducted at Chest Department, Cairo University Hospitals during the period from 2016 to 2018. This work was approved by the Departmental Ethical Committee. This study included adult pulmonary arterial hypertension (PAH) patients of group 1 after obtaining a written informed consent from each one of them, who were diagnosed by RHC.
Diagnosis of PH was based upon the diagnostic algorithm of ESC/ERS guidelines 2015 [9] . All the included patients were subjected to proper history taking and clinical examination with special emphasis on history of syncope, dyspnea grade using the modified medical research council scale, assessment of WHO functional class and manifestations of heart failure, in addition to routine laboratories, chest imaging, and echocardiography.
Anthropometric measures (height and body weight)
were obtained for all included patients. BMI was calculated according to the formula of weight (kg) divided by height (m 2 ).
The cases were categorized into five groups according to BMI with reference to the WHO cutoffs [10] . Group 1 (normal weight) with BMI 18.5-24.9 kg/m 2 . Group 2 (overweight) with BMI 25-29.9 kg/m 2 . Group 3 (class I obesity) with BMI 30-34.9 kg/m 2 . Group 4 (class II obesity) with BMI 35-39.9 kg/m 2 . Group 5 (class III obesity) with BMI more than or equal to 40 kg/m 2 .
For statistical purposes, our patients were further classified into three groups according to BMI, normal weight, overweight, and obese groups.
6MWD was performed by all patients according to ATS guidelines, 2002 [11] .
RHC was performed to all our study participants using the Swan-Ganz RHC technique, from which mPAP, mRAP, were measured, central venous oxygen saturation sampling was obtained. Risk stratification for first-year mortality was calculated based upon the ESC/ERS guidelines 2015 [9] and included: signs of heart failure, syncope, WHO functional class, 6MWD, echocardiography measurements, and RHC hemodynamics.
Statistical analysis
Data were coded and entered using the statistical package Statistical Package for the Social Sciences, version 25 (SPSS, IBM Corporation, New York, USA). Data were summarized using mean, SD, median, minimum, and maximum. Comparisons between quantitative variables were done using the nonparametric Kruskal-Wallis and Mann-Whitney tests [12] . For comparing categorical data, χ 2 test was performed. Exact test was used instead when the expected frequency is less than 5 [13] . Correlations between quantitative variables were done using Spearman's correlation coefficient [14] . P values less than 0.05 were considered as statistically significant.
Results
This study included 85 patients who shared the diagnosis of group 1 PAH. Mean age for our patients was 38.8 years (±13.57 years). Female sex was significantly predominant with male: female ratio equals about 1 : 3. All our patients were diagnosed as group 1 PH representing different underlying pathogeneses distributed as shown in (Figure 1 ).
These patients were divided according to their nutritional status (i.e. BMI) into three groups (Figure 2 ).
From (Table 1) , there were no significant statistical differences between the three study groups as regards the age, clinical presentation (heart failure, syncope, pericardial effusion). About 40% of our patients presented with clinical signs of right heart failure, the mean WHO functional class was 2.4±0.67. As regards RHC findings and PH hemodynamics, there were no significant differences between the study groups in the mean cardiac index and central venous oxygen saturation, but there were significant differences as regards the mRAP which was higher in the obese group followed by the normal and the preobese groups respectively with P value of 0.021. Surprisingly, the relationship between the BMI and 6MWD revealed significant statistical differences between the study groups, where the mean 6MWD was the highest in the preobese group (289±94 m) followed by the normal BMI group (238±106 m) and was the least in the obese group (220±102 m), showing a P value of 0.035.
Risk stratification for these patients showed higher incidence of high risk patients among the normal BMI and the preobese groups (58.6, 57%, respectively) than among the group of obese patients where about 43% of them were at high risk with significant statistical differences P value of 0.023.
Discussion
PAH is a devastating disease [15] , which results in affection of the quality of life and mortality [16] . It usually affects adult females [17, 18] , as it was found in the current study that the mean age of presentation 38.8 ±13.57 years, and the female : male ratio was found 3 : 1. Exercise tolerance of the patients as a part of assessment of quality of life is performed by either cardiopulmonary exercise testing or by 6MWD test thus used as predictors for risk of mortality in the first year [9] . Yet, there were some ethnic differences in the 6MWD [19], Al-Naamani et al. [20] found statistical significant differences in 6MWD between three different ethics studied, non-Hispanic white, African-Americans and Hispanics, which may be related to the increase in BMI [21] . Besides, the unexplained differences in the mortality indices in obese patients that were reported in many studies in the last few years, where obese patients have better outcomes than nonobese ones. Higher BMI has been shown to have protective effect on mortality in many cardiovascular and pulmonary diseases [7] , despite that different mechanisms can lead to an increase in the mPAP in obese patients including adiponectin deficiency [22] , obesity hypoventilation syndrome [23] , use of anorexigens, cardiomyopathy of obesity, pulmonary thromboembolism [20] , and other novel mechanisms: endothelial dysfunction, hyperuricemia, and insulin resistance [24] .
The term 'obesity paradox' started to emerge recently, to express such findings [25] . Thus there was an importance to discuss the impact of BMI directly in the risk assessment of mortality in the first year for patients with PAH of group 1, which was the aim of the current study. This prospective single center cohort was performed over 2 years and included all prevalent patients with PH of group 1 at time of diagnosis. The patients were categorized using WHO classification [10] into five groups, normal, overweight, class 1, class 2, and class 3 obesity. Yet due to the relative small sample size, it was recategorized into three groups based on the BMI to facilitate statistical analysis, where group 1, started from 17.5 to less than or equal to 24.9 and named 'normal,' group 2 from 25 to less than or equal to 29.9 and named 'preobese,' and group 3 with BMI more than or equal to 30 and named 'obese.'
The exact rates of PH in patients with obesity remain unclear but appear high [8] . It was found that 34.2% (n=29) of the study population related to group 1,
Figure 3
Relationship between BMI categories as regards 6MWD (a), RAP (b), and risk assessment (c). 6MWD, 6 min walk distance; RAP, right atrial pressure.
32.9% (n=28) for each of group 2 and group 3 and this was similar to the proportion of obese among the Egyptian adults according to the latest statics [26] .
The items of risk stratification were put in consideration to show if there is any correlation with BMI, there was statistical significant difference between the three groups regarding the 6MWD, where group 2 showed the best results, followed by group 1, and the obese group (group 3) showed the least distances. This U shaped relation (Figure 3 ) in favor of the preobese group was also observed in assessment of the RAP, where also best results was seen in the preobese group and worst results was seen in the obese group. The risk stratification for the mortality in the first year was calculated based on the items performed for all patients ( Table 1 ). The normal group showed highest percentage of high risk patients (n=12/28) while obese group showed the lowest percentage (n=17/29). However it showed that 16/28 of the patients in the preobese group related to the high risk stratification.
Good risk parameters, with relative high risk assessment of mortality in preobese group and the reverse in obese group (poor risk parameters with low risk stratification of mortality), denote that the fat distribution of the patient is a key point for understanding the paradox that was emerged in the current study, whereas, BMI is a simple calculation but does not consider body fat distribution. Patients with an elevated BMI may not necessarily have increased fat mass and, conversely, patients with a normal BMI may have increased abdominal fat mass. Abdominal fat mass is strongly predictive of metabolic, cardiovascular disease, and mortality [27] , women are characterized by lower intraabdominal/visceral fat accumulation and since most of our patients are female this could give some sort of explanation for this obesity paradox [28] . Hormonal changes related to obesity may play a role, where in animal model, insulin resistance coupled with moderate hypoxia results in moderate and right ventricular hypertrophy, while neither insulin nor hypoxemia alone induce PH or right ventricular hypertrophy [29] . The previous findings in the current study were similar to REVEAL registry which contained patients information suggesting that there is an ∼25% reduced risk for death by PAH in patients who are obese, but that there is an increased risk for poor 6MWD [30] .
Conclusion
In spite that obese patients have the lowest exercise tolerance and the highest mRAP, yet they have the lowest percentage of high risk patients for mortality, the underlying etiology for this obesity paradox may be not evident however correlation with the fat distribution type is recommended.
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